Vanda Pharmaceuticals Inc.

NasdaqGM:VNDA Stock Report

Market Cap: US$223.8m

Vanda Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:VNDA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Mar 24SellUS$73,379Gunther BirznieksIndividual17,411US$4.30
05 Mar 24SellUS$63,393Kevin MoranIndividual14,700US$4.48
05 Mar 24SellUS$231,339Mihael PolymeropoulosIndividual55,172US$4.24
05 Mar 24SellUS$71,921Joakim WijkstromIndividual16,727US$4.41
05 Mar 24SellUS$73,313Timothy WilliamsIndividual17,088US$4.41
21 Aug 23SellUS$21,748Joakim WijkstromIndividual3,724US$5.84
10 Aug 23SellUS$39,349Stephen MitchellIndividual6,500US$6.05
28 Jul 23SellUS$13,945Kevin MoranIndividual2,212US$6.31
15 Jun 23SellUS$100,710Kevin MoranIndividual16,000US$6.29
13 Jun 23SellUS$95,754Timothy WilliamsIndividual14,600US$6.56

Insider Trading Volume

Insider Buying: VNDA insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of VNDA?
Owner TypeNumber of SharesOwnership Percentage
State or Government00%
Private Companies18,9770.033%
Individual Insiders1,791,9343.11%
Hedge Funds3,681,1256.4%
General Public3,973,6906.91%
Institutions48,071,77383.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 71.61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.5%
BlackRock, Inc.
8,346,367US$32.5m23.5%no data
6.4%
Renaissance Technologies LLC
3,681,125US$14.3m12.7%0.02%
6.01%
The Vanguard Group, Inc.
3,456,087US$13.4m-0.55%no data
3.93%
Acadian Asset Management LLC
2,263,132US$8.8m29.3%0.02%
3.67%
D. E. Shaw & Co., L.P.
2,112,125US$8.2m8.44%0.01%
3.42%
Dimensional Fund Advisors LP
1,967,985US$7.7m-9.08%no data
3.34%
Pictet Asset Management Limited
1,919,002US$7.5m10.4%no data
2.76%
Assenagon Asset Management S.A.
1,587,717US$6.2m0%0.01%
2.63%
Morgan Stanley, Investment Banking and Brokerage Investments
1,512,186US$5.9m35.3%no data
2.49%
Jacobs Levy Equity Management Inc
1,429,850US$5.6m48%0.03%
2.27%
PGIM, Inc.
1,306,080US$5.1m10.6%0.01%
2.17%
Mihael Polymeropoulos
1,249,230US$4.9m3.83%no data
2.16%
Geode Capital Management, LLC
1,245,503US$4.8m5.62%no data
2.13%
State Street Global Advisors, Inc.
1,228,096US$4.8m-5.81%no data
1.76%
Nantahala Capital Management, LLC
1,013,251US$3.9m1.33%0.36%
1.74%
Millennium Management LLC
998,292US$3.9m-50.5%no data
1.54%
Two Sigma Advisers, LP
886,500US$3.4m15.4%0.01%
1.42%
Federated Hermes, Inc.
818,027US$3.2m-9.26%0.01%
1.36%
Two Sigma Investments, LP
783,004US$3.0m29.7%0.01%
1.12%
Charles Schwab Investment Management, Inc.
645,129US$2.5m-0.17%no data
1.08%
Citadel Advisors LLC
619,006US$2.4m-9.52%no data
0.99%
GSA Capital Partners LLP
567,756US$2.2m39.8%0.18%
0.95%
Bridgeway Capital Management, LLC
547,236US$2.1m-31.8%0.04%
0.89%
Eaton Vance Management
510,290US$2.0m8.51%no data
0.88%
Northern Trust Global Investments
508,585US$2.0m-9.4%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.